ID   CTRO_HUMAN              Reviewed;        2027 AA.
AC   O14578; Q2M5E1; Q6XUH8; Q86UQ9; Q9UPZ7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 2.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=Citron Rho-interacting kinase;
DE            Short=CRIK;
DE            EC=2.7.11.1;
DE   AltName: Full=Serine/threonine-protein kinase 21;
GN   Name=CIT; Synonyms=CRIK, KIAA0949, STK21;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Huang C.Q., Wu S.L., Shan Y.X., Liu S., Xiao P.J.;
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Mao Y., Xie Y., Wu Q.;
RT   "Cloning and characterizing a novel human CRIK-SK gene.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=15983625; DOI=10.1038/sj.mp.4001703;
RA   Lyons-Warren A., Chang J.J., Balkissoon R., Kamiya A., Garant M.,
RA   Nurnberger J., Scheftner W., Reich T., McMahon F., Kelsoe J.,
RA   Gershon E., Coryell W., Byerley W., Berrettini W., Depaulo R.,
RA   McInnis M., Sawa A.;
RT   "Evidence of association between bipolar disorder and Citron on
RT   chromosome 12q24.";
RL   Mol. Psychiatry 10:807-809(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [5]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH KIF14.
RX   PubMed=16431929; DOI=10.1083/jcb.200511061;
RA   Gruneberg U., Neef R., Li X., Chan E.H.Y., Chalamalasetty R.B.,
RA   Nigg E.A., Barr F.A.;
RT   "KIF14 and citron kinase act together to promote efficient
RT   cytokinesis.";
RL   J. Cell Biol. 172:363-372(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=16236794; DOI=10.1091/mbc.E05-06-0569;
RA   Kamijo K., Ohara N., Abe M., Uchimura T., Hosoya H., Lee J.S.,
RA   Miki T.;
RT   "Dissecting the role of Rho-mediated signaling in contractile ring
RT   formation.";
RL   Mol. Biol. Cell 17:43-55(2006).
RN   [9]
RP   INTERACTION WITH TTC3.
RX   PubMed=17488780; DOI=10.1242/jcs.000703;
RA   Berto G., Camera P., Fusco C., Imarisio S., Ambrogio C., Chiarle R.,
RA   Silengo L., Di Cunto F.;
RT   "The Down syndrome critical region protein TTC3 inhibits neuronal
RT   differentiation via RhoA and Citron kinase.";
RL   J. Cell Sci. 120:1859-1867(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-440, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433 AND SER-440, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1721, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-440, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   FUNCTION IN PHOSPHORYLATION OF MYL9/MLC2.
RX   PubMed=21457715; DOI=10.1016/j.febslet.2011.03.054;
RA   Tan I., Lai J., Yong J., Li S.F., Leung T.;
RT   "Chelerythrine perturbs lamellar actomyosin filaments by selective
RT   inhibition of myotonic dystrophy kinase-related Cdc42-binding
RT   kinase.";
RL   FEBS Lett. 585:1260-1268(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-440, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433; SER-440; SER-480;
RP   SER-582; SER-1940; SER-1993 AND THR-2013, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   FUNCTION, INVOLVEMENT IN MCPH17, VARIANTS MCPH17 VAL-106; GLN-126 AND
RP   VAL-230, AND CHARACTERIZATION OF VARIANTS MCPH17 VAL-106; GLN-126 AND
RP   VAL-230.
RX   PubMed=27453578; DOI=10.1016/j.ajhg.2016.07.004;
RA   Li H., Bielas S.L., Zaki M.S., Ismail S., Farfara D., Um K.,
RA   Rosti R.O., Scott E.C., Tu S., Chi N.C., Gabriel S., Erson-Omay E.Z.,
RA   Ercan-Sencicek A.G., Yasuno K., Caglayan A.O., Kaymakcalan H.,
RA   Ekici B., Bilguvar K., Gunel M., Gleeson J.G.;
RT   "Biallelic mutations in Citron kinase Link mitotic cytokinesis to
RT   human primary microcephaly.";
RL   Am. J. Hum. Genet. 99:501-510(2016).
RN   [21]
RP   INVOLVEMENT IN MCPH17.
RX   PubMed=27453579; DOI=10.1016/j.ajhg.2016.07.003;
RA   Harding B.N., Moccia A., Drunat S., Soukarieh O., Tubeuf H.,
RA   Chitty L.S., Verloes A., Gressens P., El Ghouzzi V., Joriot S.,
RA   Di Cunto F., Martins A., Passemard S., Bielas S.L.;
RT   "Mutations in Citron kinase cause recessive microlissencephaly with
RT   multinucleated neurons.";
RL   Am. J. Hum. Genet. 99:511-520(2016).
RN   [22]
RP   INVOLVEMENT IN MCPH17.
RX   PubMed=27503289; DOI=10.1007/s00439-016-1722-2;
RA   Shaheen R., Hashem A., Abdel-Salam G.M., Al-Fadhli F., Ewida N.,
RA   Alkuraya F.S.;
RT   "Mutations in CIT, encoding citron rho-interacting serine/threonine
RT   kinase, cause severe primary microcephaly in humans.";
RL   Hum. Genet. 135:1191-1197(2016).
RN   [23]
RP   INVOLVEMENT IN MCPH17.
RX   PubMed=27519304; DOI=10.1007/s00439-016-1724-0;
RA   Basit S., Al-Harbi K.M., Alhijji S.A., Albalawi A.M., Alharby E.,
RA   Eldardear A., Samman M.I.;
RT   "CIT, a gene involved in neurogenic cytokinesis, is mutated in human
RT   primary microcephaly.";
RL   Hum. Genet. 135:1199-1207(2016).
RN   [24]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLU-7; GLN-9 AND PHE-183.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Plays a role in cytokinesis. Required for KIF14
CC       localization to the central spindle and midbody. Putative RHO/RAC
CC       effector that binds to the GTP-bound forms of RHO and RAC1. It
CC       probably binds p21 with a tighter specificity in vivo. Displays
CC       serine/threonine protein kinase activity. Plays an important role
CC       in the regulation of cytokinesis and the development of the
CC       central nervous system. Phosphorylates MYL9/MLC2.
CC       {ECO:0000269|PubMed:16236794, ECO:0000269|PubMed:16431929,
CC       ECO:0000269|PubMed:21457715, ECO:0000269|PubMed:27453578}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Directly interacts with KIF14 depending on the activation
CC       state (stronger interaction with the kinase-dead form). Homodimer
CC       (By similarity). Interacts with TTC3. {ECO:0000250,
CC       ECO:0000269|PubMed:16431929, ECO:0000269|PubMed:17488780}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=O14578-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short, CRIK-SK;
CC         IsoId=O14578-2; Sequence=VSP_012434, VSP_012435;
CC       Name=3;
CC         IsoId=O14578-3; Sequence=VSP_014507, VSP_014508, VSP_014509;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O14578-4; Sequence=VSP_043301;
CC   -!- DISEASE: Microcephaly 17, primary, autosomal recessive (MCPH17)
CC       [MIM:617090]: A form of microcephaly, a disease defined as a head
CC       circumference more than 3 standard deviations below the age, sex
CC       and ethnically matched mean. Brain weight is markedly reduced and
CC       the cerebral cortex is disproportionately small. MCPH17 is a
CC       severe form characterized by lissencephaly, enlarged ventricles,
CC       agenesis of the corpus callosum, cerebellar hypoplasia, and
CC       brainstem hypoplasia. Patients manifest delayed psychomotor
CC       development, intellectual disability, spasticity, axial hypotonia,
CC       and dysmorphic features. {ECO:0000269|PubMed:27453578,
CC       ECO:0000269|PubMed:27453579, ECO:0000269|PubMed:27503289,
CC       ECO:0000269|PubMed:27519304}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA76793.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY257469; AAP13528.1; -; mRNA.
DR   EMBL; AY209000; AAP43922.1; -; mRNA.
DR   EMBL; AY681966; AAV87216.1; -; mRNA.
DR   EMBL; AB023166; BAA76793.2; ALT_INIT; mRNA.
DR   EMBL; AC002563; AAB71327.1; -; Genomic_DNA.
DR   EMBL; AC079317; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004813; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS55891.1; -. [O14578-4]
DR   CCDS; CCDS9192.1; -. [O14578-1]
DR   RefSeq; NP_001193928.1; NM_001206999.1. [O14578-4]
DR   RefSeq; NP_009105.1; NM_007174.2. [O14578-1]
DR   UniGene; Hs.119594; -.
DR   ProteinModelPortal; O14578; -.
DR   SMR; O14578; -.
DR   BioGrid; 116290; 15.
DR   IntAct; O14578; 5.
DR   MINT; MINT-2795177; -.
DR   STRING; 9606.ENSP00000376306; -.
DR   BindingDB; O14578; -.
DR   ChEMBL; CHEMBL5579; -.
DR   GuidetoPHARMACOLOGY; 1509; -.
DR   iPTMnet; O14578; -.
DR   PhosphoSitePlus; O14578; -.
DR   BioMuta; CIT; -.
DR   EPD; O14578; -.
DR   MaxQB; O14578; -.
DR   PaxDb; O14578; -.
DR   PeptideAtlas; O14578; -.
DR   PRIDE; O14578; -.
DR   DNASU; 11113; -.
DR   Ensembl; ENST00000261833; ENSP00000261833; ENSG00000122966. [O14578-1]
DR   Ensembl; ENST00000392521; ENSP00000376306; ENSG00000122966. [O14578-4]
DR   Ensembl; ENST00000612548; ENSP00000482318; ENSG00000122966. [O14578-2]
DR   GeneID; 11113; -.
DR   KEGG; hsa:11113; -.
DR   UCSC; uc001txi.3; human. [O14578-1]
DR   CTD; 11113; -.
DR   DisGeNET; 11113; -.
DR   GeneCards; CIT; -.
DR   GeneCards; MIR1178; -.
DR   HGNC; HGNC:1985; CIT.
DR   HPA; HPA019082; -.
DR   HPA; HPA048812; -.
DR   HPA; HPA075506; -.
DR   MIM; 605629; gene.
DR   MIM; 617090; phenotype.
DR   neXtProt; NX_O14578; -.
DR   OpenTargets; ENSG00000122966; -.
DR   PharmGKB; PA26522; -.
DR   eggNOG; KOG0612; Eukaryota.
DR   eggNOG; KOG0976; Eukaryota.
DR   eggNOG; ENOG410XR1Q; LUCA.
DR   GeneTree; ENSGT00760000118994; -.
DR   HOGENOM; HOG000015347; -.
DR   HOVERGEN; HBG071093; -.
DR   InParanoid; O14578; -.
DR   KO; K16308; -.
DR   OMA; MKAKDQG; -.
DR   OrthoDB; EOG091G00DT; -.
DR   PhylomeDB; O14578; -.
DR   TreeFam; TF101140; -.
DR   Reactome; R-HSA-5625900; RHO GTPases activate CIT.
DR   SignaLink; O14578; -.
DR   ChiTaRS; CIT; human.
DR   GeneWiki; CIT_(gene); -.
DR   GenomeRNAi; 11113; -.
DR   PRO; PR:O14578; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000122966; -.
DR   CleanEx; HS_CIT; -.
DR   ExpressionAtlas; O14578; baseline and differential.
DR   Genevisible; O14578; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031985; C:Golgi cisterna; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030165; F:PDZ domain binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0017048; F:Rho GTPase binding; IEA:Ensembl.
DR   GO; GO:0097110; F:scaffold protein binding; IDA:BHF-UCL.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0000910; P:cytokinesis; IMP:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0048699; P:generation of neurons; ISS:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0000281; P:mitotic cytokinesis; IMP:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; ISS:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0008064; P:regulation of actin polymerization or depolymerization; IEA:Ensembl.
DR   CDD; cd00029; C1; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR017405; Citron_Rho-interacting_kinase.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR22988:SF44; PTHR22988:SF44; 1.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Cell cycle;
KW   Cell division; Coiled coil; Complete proteome; Cytoplasm;
KW   Developmental protein; Differentiation; Disease mutation; Kinase;
KW   Metal-binding; Mitosis; Neurogenesis; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Primary microcephaly;
KW   Reference proteome; Serine/threonine-protein kinase; SH3-binding;
KW   Transferase; Zinc; Zinc-finger.
FT   CHAIN         1   2027       Citron Rho-interacting kinase.
FT                                /FTId=PRO_0000085908.
FT   DOMAIN       97    360       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      361    431       AGC-kinase C-terminal.
FT   DOMAIN     1443   1563       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN     1591   1881       CNH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00795}.
FT   NP_BIND     103    111       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ZN_FING    1362   1411       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   REGION     1091   1302       Interaction with Rho/Rac.
FT   COILED      453   1297       {ECO:0000255}.
FT   MOTIF      1953   1958       SH3-binding. {ECO:0000255}.
FT   ACT_SITE    221    221       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     126    126       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     433    433       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     440    440       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     480    480       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     582    582       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1196   1196       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P49025}.
FT   MOD_RES    1721   1721       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES    1940   1940       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1993   1993       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    2013   2013       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    467       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10231032}.
FT                                /FTId=VSP_014507.
FT   VAR_SEQ     481    482       EV -> GG (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_012434.
FT   VAR_SEQ     483   2027       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_012435.
FT   VAR_SEQ     694    694       E -> EERRHSLENKVKRLETMERRENRLKDDIQTKSQQIQ
FT                                QMADKIL (in isoform 4).
FT                                {ECO:0000303|PubMed:15983625}.
FT                                /FTId=VSP_043301.
FT   VAR_SEQ    1239   1253       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10231032}.
FT                                /FTId=VSP_014508.
FT   VAR_SEQ    1919   1919       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:10231032}.
FT                                /FTId=VSP_014509.
FT   VARIANT       7      7       G -> E (in dbSNP:rs36054900).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040417.
FT   VARIANT       9      9       R -> Q (in dbSNP:rs56193743).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040418.
FT   VARIANT     106    106       G -> V (in MCPH17; impairs kinase
FT                                activity; exhibits abnormal mitotic
FT                                cytokinesis; exhibits multipolar
FT                                spindles; increases the neurons apoptotic
FT                                process). {ECO:0000269|PubMed:27453578}.
FT                                /FTId=VAR_077442.
FT   VARIANT     126    126       K -> Q (in MCPH17; impairs kinase
FT                                activity; exhibits abnormal mitotic
FT                                cytokinesis; exhibits multipolar
FT                                spindles; increases the neurons apoptotic
FT                                process). {ECO:0000269|PubMed:27453578}.
FT                                /FTId=VAR_077443.
FT   VARIANT     183    183       L -> F. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040419.
FT   VARIANT     230    230       D -> V (in MCPH17; impairs kinase
FT                                activity; exhibits abnormal mitotic
FT                                cytokinesis; exhibits multipolar
FT                                spindles; increases the neurons apoptotic
FT                                process). {ECO:0000269|PubMed:27453578}.
FT                                /FTId=VAR_077444.
FT   CONFLICT     12     12       L -> S (in Ref. 2; AAP43922).
FT                                {ECO:0000305}.
FT   CONFLICT     56     56       F -> L (in Ref. 2; AAP43922).
FT                                {ECO:0000305}.
FT   CONFLICT    218    218       V -> L (in Ref. 2; AAP43922).
FT                                {ECO:0000305}.
SQ   SEQUENCE   2027 AA;  231431 MW;  6B1D8C3F661F357B CRC64;
     MLKFKYGARN PLDAGAAEPI ASRASRLNLF FQGKPPFMTQ QQMSPLSREG ILDALFVLFE
     ECSQPALMKI KHVSNFVRKY SDTIAELQEL QPSAKDFEVR SLVGCGHFAE VQVVREKATG
     DIYAMKVMKK KALLAQEQVS FFEEERNILS RSTSPWIPQL QYAFQDKNHL YLVMEYQPGG
     DLLSLLNRYE DQLDENLIQF YLAELILAVH SVHLMGYVHR DIKPENILVD RTGHIKLVDF
     GSAAKMNSNK MVNAKLPIGT PDYMAPEVLT VMNGDGKGTY GLDCDWWSVG VIAYEMIYGR
     SPFAEGTSAR TFNNIMNFQR FLKFPDDPKV SSDFLDLIQS LLCGQKERLK FEGLCCHPFF
     SKIDWNNIRN SPPPFVPTLK SDDDTSNFDE PEKNSWVSSS PCQLSPSGFS GEELPFVGFS
     YSKALGILGR SESVVSGLDS PAKTSSMEKK LLIKSKELQD SQDKCHKMEQ EMTRLHRRVS
     EVEAVLSQKE VELKASETQR SLLEQDLATY ITECSSLKRS LEQARMEVSQ EDDKALQLLH
     DIREQSRKLQ EIKEQEYQAQ VEEMRLMMNQ LEEDLVSARR RSDLYESELR ESRLAAEEFK
     RKATECQHKL LKAKDQGKPE VGEYAKLEKI NAEQQLKIQE LQEKLEKAVK ASTEATELLQ
     NIRQAKERAE RELEKLQNRE DSSEGIRKKL VEAEELEEKH REAQVSAQHL EVHLKQKEQH
     YEEKIKVLDN QIKKDLADKE TLENMMQRHE EEAHEKGKIL SEQKAMINAM DSKIRSLEQR
     IVELSEANKL AANSSLFTQR NMKAQEEMIS ELRQQKFYLE TQAGKLEAQN RKLEEQLEKI
     SHQDHSDKNR LLELETRLRE VSLEHEEQKL ELKRQLTELQ LSLQERESQL TALQAARAAL
     ESQLRQAKTE LEETTAEAEE EIQALTAHRD EIQRKFDALR NSCTVITDLE EQLNQLTEDN
     AELNNQNFYL SKQLDEASGA NDEIVQLRSE VDHLRREITE REMQLTSQKQ TMEALKTTCT
     MLEEQVMDLE ALNDELLEKE RQWEAWRSVL GDEKSQFECR VRELQRMLDT EKQSRARADQ
     RITESRQVVE LAVKEHKAEI LALQQALKEQ KLKAESLSDK LNDLEKKHAM LEMNARSLQQ
     KLETERELKQ RLLEEQAKLQ QQMDLQKNHI FRLTQGLQEA LDRADLLKTE RSDLEYQLEN
     IQVLYSHEKV KMEGTISQQT KLIDFLQAKM DQPAKKKKGL FSRRKEDPAL PTQVPLQYNE
     LKLALEKEKA RCAELEEALQ KTRIELRSAR EEAAHRKATD HPHPSTPATA RQQIAMSAIV
     RSPEHQPSAM SLLAPPSSRR KESSTPEEFS RRLKERMHHN IPHRFNVGLN MRATKCAVCL
     DTVHFGRQAS KCLECQVMCH PKCSTCLPAT CGLPAEYATH FTEAFCRDKM NSPGLQTKEP
     SSSLHLEGWM KVPRNNKRGQ QGWDRKYIVL EGSKVLIYDN EAREAGQRPV EEFELCLPDG
     DVSIHGAVGA SELANTAKAD VPYILKMESH PHTTCWPGRT LYLLAPSFPD KQRWVTALES
     VVAGGRVSRE KAEADAKLLG NSLLKLEGDD RLDMNCTLPF SDQVVLVGTE EGLYALNVLK
     NSLTHVPGIG AVFQIYIIKD LEKLLMIAGE ERALCLVDVK KVKQSLAQSH LPAQPDISPN
     IFEAVKGCHL FGAGKIENGL CICAAMPSKV VILRYNENLS KYCIRKEIET SEPCSCIHFT
     NYSILIGTNK FYEIDMKQYT LEEFLDKNDH SLAPAVFAAS SNSFPVSIVQ VNSAGQREEY
     LLCFHEFGVF VDSYGRRSRT DDLKWSRLPL AFAYREPYLF VTHFNSLEVI EIQARSSAGT
     PARAYLDIPN PRYLGPAISS GAIYLASSYQ DKLRVICCKG NLVKESGTEH HRGPSTSRSS
     PNKRGPPTYN EHITKRVASS PAPPEGPSHP REPSTPHRYR EGRTELRRDK SPGRPLEREK
     SPGRMLSTRR ERSPGRLFED SSRGRLPAGA VRTPLSQVNK VWDQSSV
//
